Morning Pre-Conference Short Course* 

Enhancing the Quality of Portfolio Decisions - Detailed Agenda 

Elayne Ko, M.S., Manager, Advisory, Deloitte Financial Advisory Services LLP

Pharmaceutical companies are facing more and more challenges with portfolio investment decisions in light of increasing budget constraints. Project teams and portfolio management groups are sometimes confused by the portfolio decisions made by decision-makers, resulting in frustration and perhaps even impacting morale and productivity. Decision-makers have many issues to consider when making portfolio decisions; decision-making process highlights ways to identify the multiple objectives that exists. The workshop provides details on ways to improve the portfolio prioritization decision-making process to account for multiple objectives, resulting in greater transparency and quality of decisions which are vital to the eventual success of the pharmaceutical companies.

*Separate registration is required. 

Interactive Breakout Discussion Groups 

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest to them and become an active part of the discussion at hand. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing.

Topics may include:

• Designing and tailoring strategic and flexible resource management systems specifically for pharma R&D
• Applying weights to quantitative and qualitative criteria for improved decision making
• Incorporating a globalized workforce and other resourcing options (off-shoring, in-sourcing, in-out licensing and risk-sharing) into capacity management
• Building partnerships between project management, resource management, functional management, and finance to drive productivity
• Resource management: centralized vs. decentralized
• Achieving more effective real-time portfolio management and resource allocation

Please share your topic requests and suggestions with us: lyuan@healthtech.com 

» OPENING KEYNOTE PRESENTATION 

Approaches to Portfolio Management and Strategic Planning

Chetan Panwala, Ph.D., MBA, Director, Global Project Management, Allergan

Luncheon Presentation

Using Portfolio Management to Effectively Manage (and Not Manage) Innovation

Daniel Smith, MBA, Vice President, Enrich Consulting

Interactive Breakout Discussion Groups 

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest to them and become an active part of the discussion at hand. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing.

Topics may include:

• Understanding the impact of partnerships and co-development deals on resource and portfolio management
• Supporting agile development and agile adaptation of data into planning: How to manage uncertainty, react to outcomes efficiently, and create an agile and efficient organization
• Tying forecasting function successfully into portfolio management
• Aligning portfolio & productivity with corporate strategy to drive strategic resource allocation
• Balancing internal R&D investments and resources with external collaborations
• Right sizing: How can capacity management contribute to right sizing and outsourcing?
• Creating a governance body and corporate structure to enable agile decision making
• How can pharma translate lessons learned from other industries?

Please share your topic requests and suggestions with us: lyuan@healthtech.com 

Tuesday Dinner Short Course* 

Optimizing Trial Resourcing through Operational Benchmarking & Ensuring Alignment between Study Goals and Activities - Detailed Agenda 

Jeffrey Handen, Ph.D., Vice President, Clinical Solutions, Medidata Solutions

Sponsor companies are increasingly struggling with having to balance more choices and activities against even less resources than before, as R&D budgets as a whole have started to decrease across the industry. More often than not portfolio decisions are made on the basis of scientific and commercial impact with little to no consideration of resourcing and operational. The audience will gain an understanding and insights into best practices from case studies and benchmark data on how sponsors are using better resource estimating of complete trial activities to manage budget, headcount, and outsourcing considerations, and to identify and minimize non value-added work, in order to free up resources for further value-added work in support of scientific and commercial goals.

*Separate registration is required. 

For questions or suggestions about the meeting, please contact:
Micah Lieberman
Executive Director, Conferences
BioPharma Strategy Series
Cambridge Healthtech Institute (CHI)
T: (+1) 541.482.4709
E: mlieberman@healthtech.com 

For exhibit and partnering information, please contact:
Joseph Vacca
Business Development Manager
BioPharma Strategy Series
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5431
E: jvacca@healthtech.com 

For media and association partnerships, please contact:
Bethany Gray
Marketing Manager
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5494
E:  bgray@healthtech.com